Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC)

Peer Review reports

Original Submission
4 Dec 2017	Submitted	Original manuscript
23 Feb 2018	Reviewed	Reviewer Report - Bethan Copsey
13 Mar 2018	Reviewed	Reviewer Report - Shengyuan Luo
14 Mar 2018	Reviewed	Reviewer Report - Daniel Beever
26 Mar 2018	Author responded	Author comments - Nefyn Williams
Resubmission - Version 2
26 Mar 2018	Submitted	Manuscript version 2
28 Mar 2018	Reviewed	Reviewer Report - Shengyuan Luo
14 Jun 2018	Reviewed	Reviewer Report - Vincent Cheng
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
9 Jul 2018	Editorially accepted
31 Jul 2018	Article published	10.1186/s13063-018-2801-6

Back to article page